News
Pfizer and BioNTech Initiate Rolling Submission for EUA of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From...
Pfizer Inc. and BioNTech SE announced that following a request from the U.S. FDA the companies have initiated a rolling submission seeking to amend...
Press Releases
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced the U.S. FDA has approved the Biologics License Application (BLA) for...
News
Britain To Finally Vaccinate 5-11 Year Old’s Against COVID
Britain has already been slow to vaccinate its 5-11 year olds, and they are now not vaccinating them as widely as the United States...
News
Recipharm acquires GenIbet to bolster Biologics offering
Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological...
News
Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis
Samsung Biologics announced that it has reached an agreement with Biogen for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for...
Press Releases
Scitara joins BioPhorum global collaboration to drive scientific advancements in biopharmaceutical sector
Scitara, proven innovator in laboratory digital transformation, announces it has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical...
News
Nasal Covid-19 Vaccine From Bharat Biotech, A Possibility
Bharat Biotech has been granted permission by India’s drug controller to execute standalone phase 3 clinical trials on the intranasal vaccine for COVID-19. Besides...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read